Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 831Session 2026

What changed between versions

19 paragraphs changed+208 words added−103 removed

Highlighted text was added in the newer version. Struck-through text was removed.

OFFERED FOR CONSIDERATION

1/23/2026

2026 SESSION

INTRODUCED

26103422D

HOUSE BILL NO. 831

AMENDMENT IN THE NATURE OF A SUBSTITUTE

Offered January 14, 2026

Prefiled January 13, 2026

A BILL to direct the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling.

—————

Patron—Kent

—————

(ProposedReferred by the Houseto Committee on Rules

on ________________)

(Patron Prior to Substitute—Delegate Kent)

A BILL to direct the Department of Health to make available on its website a list of medications, drugs, or vaccines that include gluten.

—————

Be it enacted by the General Assembly of Virginia:

1. § 1. That the Department of Health (the Department) shall make publicly available on its website a list of any medication s , drug s , or vaccine s commonly sold or distributed in the Commonwealth that include gluten as an active or inactive ingredient . The Department shall make such information available by December 1, 2026.

1. § 1. That the Board of Pharmacy shall convene a work group of relevant stakeholders to study medication, drug, and vaccine ingredient labeling. In completing its work, the work group shall (i) review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (a) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (b) accompanying informational inserts are readily available to consumers at a pharmacy upon request and (ii) study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The Board shall report the work group's findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by Dec ember 1, 202 6 .

Back to the full text